Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8221108 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 8 Pages |
Abstract
Galectin-1 is an independent prognostic factor associated with LR and CSS in stage I-II cervical cancer patients undergoing definitive radiation therapy. Further studies targeting galectin-1 may improve the local control of cervical cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eng-Yen MD, PhD, Chan-Chao MD, Hao MD, Chung-Chi MS, Chong-Jong MD, Chao-Cheng MD, PhD,